Nanoco has secured just under £1m grant funding for a life sciences project to develop a heavy metal-free quantum dot testing kit to detect COVID-19. The project will last 18 months and represents a potential third segment for generating future revenues in addition to established activities in sensing and display applications. We make minor adjustments to our estimates, although there is no impact on EBITDA or cash flow.
26 Nov 2020
Nanoco Group - Grant funding for life sciences project
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Nanoco Group - Grant funding for life sciences project
Nanoco Group PLC (NANO:LON) | 21.4 0.1 1.9% | Mkt Cap: 69.3m
- Published:
26 Nov 2020 -
Author:
Anne Margaret Crow -
Pages:
3
Nanoco has secured just under £1m grant funding for a life sciences project to develop a heavy metal-free quantum dot testing kit to detect COVID-19. The project will last 18 months and represents a potential third segment for generating future revenues in addition to established activities in sensing and display applications. We make minor adjustments to our estimates, although there is no impact on EBITDA or cash flow.